Research Article: Weight and BMI Changes Following Initiation of Emtricitabine/Tenofovir Alafenamide Co-Formulated with Darunavir or Co-Administered with Dolutegravir in Overweight or Obese, ART-Naïve People Living with HIV-
Introduction:
The emergence of antiretroviral therapy (ART) to treat people living with HIV- (PLWH) has resulted in marked improvements in life expectancy, clinical outcomes, and quality of life. – However, the longer life expectancy reported among PLWH in United States (US) has also led to an increase in the prevalence of chronic cardiometabolic disease and other aging-related comorbidities for PLWH treated with ART. , As the prevalence of obesity has also increased among ART initiators (from % in to % in ), weight gain has…
Read more